Target intelligence / Profile preview

Acid-base homeostasis pathways

Molecular classification
Enzyme, Transporter, Ion channel, Other
01

Overview

Acid-base homeostasis pathways represent the complex physiological systems responsible for maintaining the body's pH within a narrow range, typically 7.35 to 7.45, which is critical for protein function and cellular metabolism (StatPearls, 2023). These pathways involve a coordinated effort between chemical buffering systems, respiratory regulation of carbon dioxide, and renal regulation of bicarbonate and hydrogen ions (NIH, 2022). Key molecular players within these pathways include carbonic anhydrases, sodium-hydrogen exchangers (NHEs), and various bicarbonate transporters such as those in the SLC4 family (Hamm et al., 2015). Dysregulation of these pathways leads to clinical conditions such as metabolic or respiratory acidosis and alkalosis, which are frequently observed in chronic kidney disease or respiratory failure. Pharmacological intervention focuses on specific components of the pathway, such as carbonic anhydrase inhibitors for glaucoma or altitude sickness, and oral alkali or acid binders for chronic metabolic acidosis. Maintaining this balance is essential for preventing systemic complications, including bone loss and muscle wasting associated with chronic acid retention.

Other names
pH regulationAcid-base balanceAcid-base regulationAcid-base physiology
02

Mechanism of action

Drugs targeting these pathways typically inhibit specific enzymes like carbonic anhydrase to promote bicarbonate excretion, block ion exchangers like NHE3 to modulate sodium and proton flux, or act as buffers to neutralize excess acid in the blood or gastrointestinal tract (StatPearls, 2023; Hamm et al., 2015).

03

Biological functions

pH regulationMetabolic homeostasisIon transportGas exchangeRenal compensationRespiratory compensation
04

Disease associations

Metabolic acidosisMetabolic alkalosisRespiratory acidosisRespiratory alkalosisChronic kidney diseaseRenal tubular acidosisDistal renal tubular acidosis
05

Safety considerations

Electrolyte imbalances (e.g., hypokalemia, hyponatremia)Metabolic alkalosis due to overcorrectionVolume depletionCalcium-phosphate depositionRespiratory depression (in compensatory states)
06

Interacting drugs

Acetazolamide

6 more in the full profile.

07

Biomarkers

Serum bicarbonate (HCO3-)Arterial blood pHPartial pressure of carbon dioxide (pCO2)Anion gapUrinary pHBase excess

Beyond the preview

Go deeper on Acid-base homeostasis pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acid-base homeostasis pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call